The regulation of RGS2 was also experimentally assessed together with its impact on tumour cell phenotype and effects on relevant signalling pathways corresponding to the phenotypic outcome of aberrant RGS2 expression in PC. Here, RGS2 is linked to pachyonychia congenita.